text: Onyx Disappointment Is Good News For Genentech Credit Suisse First Boston said that an announcement from Onyx Pharmaceuticals (nasdaq: ONXX - news - people ) is  quot;good news quot; for Genentech (nyse: DNA - news - people ) and its Avastin treatment.